JUNS — JUPITER NEUROSCIENCES, INC.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1679628 ·
Last close
$1.52
Market Cap
$2.00M
52W High
$101.25
52W Low
$1.47
ADV30
21,717
Next earnings
—

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 13,942 9,608 -5,795,706 -7,224,070 1,623,134 300,623 2,785,136
Jun 2026 24,245 21,064 -2,742,945 -2,274,397 3,718,600 1,521,874 4,084,566
Mar 2026 18,652 14,290 -1,963,000 -2,061,958 3,948,584 2,362,749 6,732,041
Dec 2025 21,796 — -2,808,785 -2,575,031 5,564,030 3,789,342 7,395,882

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-7,249,495
Investing CF
—
Financing CF
$6,893,122
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-18.92
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-39,003,381
Inventory
$135,290
Receivables
$10,241
ST Investments
—
EBIT TTM
$-8,926,502
Pretax Income TTM
$-9,199,420
Interest Exp TTM
$272,918
Analysts
—

Yahoo Snapshot (yfinance, live)

Total Revenue
$64,693
EBITDA
—
Free Cash Flow
$-3,261,390
Enterprise Value
$2,575,949
Total Cash
$1,521,874
Total Debt
$1,749,076
Shares Out
1,318,521
Trailing EPS
$-18.70
Book Value
$-0.55
ROE
-1888.7%
ROA
-159.6%
Div Yield
—

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 21,796 -8,908,721 -8,644,897 5,560,000 7,395,882 -1,831,852 -5,413,736
Dec 2024 0 -3,091,282 -2,439,625 6,200,000 2,030,401 4,172,008 -3,911,004
Dec 2023 0 -3,870,771 -4,783,689 148,592 5,949,946 -5,801,354 -480,953
Dec 2022 233,281 -3,432,447 -4,957,580 235,944 7,380,028 -7,144,084 -1,248,504

TTM Snapshot

Revenues TTM
$41,278
NetIncome TTM
$-9,199,420
OpCashFlow TTM
—
Assets (Latest)
$3,718,600
Forward EPS
$0.06

Peers — same industry

TickerNameMarket CapLastDaily %
JAGX Jaguar Health, Inc. $1.96M $0.38 —
CASIF CASI Pharmaceuticals, Inc. $2.06M $0.10 —
PPCB Propanc Biopharma, Inc. $1.94M $1.88 —
XRTX XORTX Therapeutics Inc. $1.93M $1.06 —
SBFM Sunshine Biopharma Inc. $2.09M $2.54 —

News headlines (Yahoo Finance, 1h cache)

Sector Update: Healthcare Stocks Mixed Late Afternoon
2026-10-06 19:51 · Yahoo
Sector Update: Healthcare Stocks Mixed Tuesday Afternoon
2026-10-06 17:46 · Yahoo
Jupiter Neurosciences Announces First Patient Dosed in Phase 2a RESET Trial in Parkinson’s Disease and Exploration of Strategic Options to Maximize Shareholder Value
2026-10-06 15:15 · Yahoo
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
2026-08-31 14:12 · Yahoo
Real Parkinson’s Disease Hope from Jupiter Neurosciences
2026-08-19 16:32 · Yahoo
Psychedelic Therapy Meets M&A: Fireside Chat with Jupiter Neurosciences CEO Christer Rosén & President Alison Silva
2026-07-22 17:25 · Yahoo
Jupiter Neurosciences Signs ALA-002 License Agreement Worth Up to $100 Million (NASDAQ:JUNS)
2026-07-21 14:27 · Yahoo
PharmAla Biotech Executes Definitive License Agreement Granting Jupiter Neurosciences Exclusive U.S. Rights to ALA-002
2026-07-21 11:00 · Yahoo
Jupiter Neurosciences (NASDAQ: JUNS) Signs Definitive Agreement for Exclusive U.S. Rights to ALA-002 in Transaction Valued at Up to $100 Million
2026-07-21 11:13 · Yahoo
Jupiter Neurosciences Announces Pricing of $2.0 Million Registered Direct Offering
2026-05-20 18:38 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.